UNSPSC 51351505: Ethisterone

This classification denotes a therapeutic progestin with the molecular formula C21H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P201BVY1MJ, chemically known as 17.alpha.-pregn-4-en-20-yn-3-one, 17-hydroxy- but generally known as ethisterone, which bears US NIH Compound Identifier 3288. European Medicines Agency schedules Ethisterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07279MIG.

UNSPSC 51351505 Ethisterone, a Commodity code, addresses procurement of a synthetic progestin pharmaceutical used in contraceptive formulations and hormone-replacement therapies. State and local health departments, correctional facilities, and public health agencies source this active pharmaceutical ingredient for inclusion in birth-control products, emergency contraception protocols, and clinical formularies distributed through public clinics and institutional healthcare systems. The code captures bulk pharmaceutical procurement rather than finished dosage forms, reflecting procurement chains where jurisdictions acquire raw or semi-processed pharmaceutical inputs for compounding, repackaging, or direct therapeutic use within government-operated or government-contracted healthcare delivery networks.

The source provided contains no record of recent state and local contract opportunities tagged to UNSPSC 51351505. Without posted solicitation activity, market characterization by issuing-body type, geography, or representative procurement drivers cannot be drawn from current market signals. Firms monitoring this code should track state pharmacy benefit managers, state Medicaid agencies, and county health departments for formulary updates and bulk-purchase RFPs, which typically emerge during annual contract renewal cycles; however, no active opportunities are present in the available data as of 2026-10-20.